# OnCo record rezatapopt (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/rezatapopt/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "rezatapopt" ;
  schema:name "Rezatapopt"@en ;
  schema:alternateName "PC14586"@en ;
  schema:description "Rezatapopt is an experimental pill from PMV Pharma, in phase 2 trials for solid tumours with the TP53 Y220C mutation."@en ;
  schema:url <https://onco.cc/drugs/rezatapopt/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.pmvpharma.com/pipeline/>, <https://clinicaltrials.gov/study/NCT04585750>, <https://clinicaltrials.gov/study/NCT07372625>, <https://clinicaltrials.gov/study/NCT06616636> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule, oral" ;
  onco:targets <https://onco.cc/targets/tp53/> ;
  onco:companies <https://onco.cc/companies/pmv-pharma/> ;
  onco:trials <https://onco.cc/trials/nct04585750/>, <https://onco.cc/trials/nct07372625/>, <https://onco.cc/trials/nct06616636/> .
